Pharma BD Deal Intelligence
DSM acquired Roche's Vitamins & Fine Chemicals division for EUR 2.25B (approximately $2.24B) as part of Roche's refocus on its pharmaceuticals and diagnostics pillars following its vitamin price-fixing settlements. The transaction cleared on conditions, with the FTC requiring divestiture of the feed-phytase business to BASF and the EU Commission granting clearance in July 2003. DSM completed the acquisition with effect from September 30, 2003 and renamed the business DSM Nutritional Products.